The US Food and Drug Administration’s ability to communicate with social media companies like Facebook about inaccurate scientific and medical information is likely on safer grounds following oral arguments at the Supreme Court on 18 March.
The majority of the justices seemed unlikely to uphold a US Court of Appeals for the 5th Circuit ruling that...





